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Autosomal Dominant Optic Atrophy (ADOA), a disease that causes blindness and other
neurological disorders, is linked to OPA1 mutations. OPA1, dependent on its GTPase and
GED domains, governs inner mitochondrial membrane (IMM) fusion and cristae
organization, which are central to oxidative metabolism. Mitochondrial dynamics and
IMM organization have also been implicated in Ca2+ homeostasis and signaling but the
speciﬁc involvements of OPA1 in Ca2+ dynamics remain to be established. Here we
studied the possible outcomes of OPA1 and its ADOA-linked mutations in Ca2+
homeostasis using rescue and overexpression strategies in Opa1-deﬁcient and wildtype murine embryonic ﬁbroblasts (MEFs), respectively and in human ADOA-derived
ﬁbroblasts. MEFs lacking Opa1 required less Ca2+ mobilization from the endoplasmic
reticulum (ER) to induce a mitochondrial matrix [Ca2+] rise ([Ca2+]mito). This was associated
with closer ER-mitochondria contacts and no signiﬁcant changes in the mitochondrial
calcium uniporter complex. Patient cells carrying OPA1 GTPase or GED domain mutations
also exhibited altered Ca2+ homeostasis, and the mutations associated with lower OPA1
levels displayed closer ER-mitochondria gaps. Furthermore, in Opa1−/− MEF background,
we found that acute expression of OPA1 GTPase mutants but no GED mutants, partially
restored cytosolic [Ca2+] ([Ca2+]cyto) needed for a prompt [Ca2+]mito rise. Finally, OPA1
mutants’ overexpression in WT MEFs disrupted Ca2+ homeostasis, partially recapitulating
the observations in ADOA patient cells. Thus, OPA1 modulates functional ERmitochondria coupling likely through the OPA1 GED domain in Opa1−/− MEFs.
However, the co-existence of WT and mutant forms of OPA1 in patients promotes an
imbalance of Ca2+ homeostasis without a domain-speciﬁc effect, likely contributing to the
overall ADOA progress.
Keywords: mitochondria, OPA1, ADOA, calcium, endoplasmic reticulum
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INTRODUCTION

associated with a decrease in cristae number (Kushnareva et al.,
2013). In a different study, ADOA-derived ﬁbroblasts from a
family carrying the same OPA1 GTPase mutation showed an
enhanced Ca2+
mito uptake upon IP3R stimulation but with a wide
variety of responses between patients (Fülöp et al., 2015). And,
expression of ADOA-causing mutants in mice RGCs and
nematode motorneurons, resulted in augmented Ca2+
cyto levels
(Zaninello et al., 2021). Yet, over 400 different pathogenic
OPA1 variants have been described in the Leiden Open
Variation Database, LOVD (Le Roux et al., 2019) or ClinVar
Database (Landrum et al., 2018) which can affect different
domains such as the GTPase and GED domain among others.
Finally, it is clear that OPA1 loss alters Ca2+ homeostasis, but the
mechanisms involved still remain elusive.
Ca2+ uptake across the IMM is mediated by the mtCU
complex. The protein core of this highly regulated complex is
composed of the mitochondrial Ca2+ uniporter (MCU), the
essential MCU regulator (EMRE), and the dominant-negative
MCU subunit (MCUb) (Baughman et al., 2011; De Stefani et al.,
2011; Raffaello et al., 2013; Sancak et al., 2013). The MCU activity
and Ca2+ threshold are controlled by the mitochondrial calcium
uniporter proteins (MICU1/2/3) (Perocchi et al., 2010;
Mallilankaraman et al., 2012; Csordás et al., 2013; Kamer
et al., 2017; Patron et al., 2019). An interaction between OPA1
and the MCU-MICU1 complex has been recently described
(Herkenne et al., 2020). Also, OPA1 interacts with the
mitochondrial cristae and contact site organizing system
(MICOS) complex and MICU1, suggesting a role for MICU1
on cristae junction regulation (Gottschalk et al., 2019; Tomar
et al., 2019). These data suggest that the role of OPA1 on Ca2+
homeostasis may involve mechanisms beyond its fusion activity.
High-resolution imaging experiments have shown that cristae
are dynamic (Kondadi et al., 2020) and they move throughout the
mitochondria in an OPA1-dependent manner (Gottschalk et al.,
2018). Cristae localized close to ER-mitochondria contacts
decelerate upon IP3R stimulation probably to support ERmitochondria Ca2+ transfer (Gottschalk et al., 2018),
reinforcing the potential role of OPA1 on Ca2+
mito signaling.
In this work, we studied the role of OPA1 and its disease
2+
causing mutations in Ca2+
mito responses upon local or bulk Cacyto
signaling. We show that OPA1 is necessary to regulate ER-tomitochondria Ca2+ transfer. We also demonstrate that OPA1
GTPase and GED, which are known to cause ADOA when
pathogenic mutants are present, differentially alter Ca2+
mito
homeostasis, with the GED domain playing a key role in ERto-mitochondria functional coupling. In addition, the coexistence
of all studied mutant and wild-type (WT) forms of OPA1
indistinctly disrupts Ca2+ homeostasis, potentially contributing
to ADOA disease progression.

Mitochondria are compartmentalized and dynamic organelles that
undergo multiple membrane reshaping processes (Eisner et al.,
2018). Mitochondria reshaping involves mitochondrial fusion,
ﬁssion, and IMM folding. The GTPase protein, OPA1, is the
master regulator of IMM reshaping; controlling IMM fusion,
folding, cristae biogenesis, and cristae shape (Liu et al., 2009;
Song et al., 2009; Varanita et al., 2015; Glytsou et al., 2016; Hu
et al., 2020). Mitochondrial cristae host OXPHOS supercomplexes
and support mitochondrial and cellular metabolism (Vogel et al.,
2006; Cogliati et al., 2013). The multiple functions of OPA1 rely on
several domains, which include the GTPase domain and the GTPase
effector domain (GED) (Landes et al., 2010).
Ca2+ controls OXPHOS and in turn, ATP production by
activating different dehydrogenases and supporting pyruvate
supply inside the mitochondria (Denton, 1990; Hajnóczky
et al., 1995; Jouaville et al., 1999). Ca2+ is principally stored at
the Endoplasmic Reticulum (ER), and its release to the cytosol is
mediated through the activation of the IP3 receptor (IP3R) or the
Ryanodine receptor (Berridge, 2016). Mitochondria can
physically interact with the ER through multiple protein
tethers to facilitate the local Ca2+ transfer from the ER to
mitochondria, and cytosolic Ca2+ (Ca2+
cyto) clearance (Rizzuto
et al., 1998; Csordás et al., 1999; Csordás et al., 2006).
Mitochondrial Ca2+ (Ca2+
mito) uptake is determined by: 1) the
Voltage-dependent Anion Selective Channels (VDACs) and
Mitochondrial Calcium Uniporter complex (mtCU), located at
the outer mitochondrial membrane (OMM) and IMM,
respectively; and 2) Δψm, which is the main component of the
electrochemical gradient acting as the driving force (Gunter and
Sheu, 2009; Rizzuto et al., 2012; Hajnóczky et al., 2014). In
addition, mitochondrial morphology is a potential modulator
of Ca2+
mito homeostasis that needs further investigation (Szabadkai
et al., 2004; Szabadkai et al., 2006; Kowaltowski et al., 2019).
Pathogenic mutations in OPA1 trigger Autosomal Dominant
Optic Atrophy (ADOA, MIM#165500) which causes blindness due
to Retinal Ganglion Cells (RGCs) death (Delettre et al., 2000;
Olichon et al., 2003; Amati-Bonneau et al., 2008). OPA1
dysfunction induces IMM fusion abolition, IMM rearrangement,
cristae shape disturbance and metabolic disruption (Song et al., 2009;
Patten et al., 2014). The axons of mice RGCs expressing ADOA
mutants, show drastic mitochondrial depletion, due to
autophagosome accumulation at axonal hillocks in a AMPKdependent manner (Zaninello et al., 2020).
The relevance of OPA1 in Ca2+ homeostasis has been
described in the literature with many discrepancies between
different groups. Knockdown of Opa1 in RGCs caused altered
2+
(Ca2+
Ca2+
cyto clearance upon ER Ca
ER) release and excitotoxicity,
suggesting that OPA1 may have a role in Ca2+ homeostasis and
disease progress (Dayanithi et al., 2010; Kushnareva et al., 2013).
However, silencing of OPA1 in HeLa and H295R cell lines
induced enhanced Ca2+
mito uptake upon IP3R activation despite
low Δψm and mitochondrial morphology changes (Fülöp et al.,
2011). In contrast, another group showed that OPA1 knockdown
in HeLa cells displayed diminished Ca2+
mito uptake upon IP3R
stimulation with serious defects on Ca2+
mito retention capacity,
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RESULTS
OPA1 is Required for Cytosolic and
Mitochondrial Ca2+ Homeostasis
To test the relevance of OPA1 in Ca2+ homeostasis, we ﬁrst used
MEFs in which the mitochondrial matrix-targeted Ca2+-sensitive
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FIGURE 1 | OPA1 is required for cytosolic and mitochondrial Ca2+ homeostasis. (A) ER-dependent mitochondrial Ca2+ uptake, schematic experimental design.
WT, Opa1−/− or acute rescued Opa1−/− MEF Cells with OPA1 WT isoform 1, expressing mtRCaMP, and the muscarinic receptor 3 (M3R), were incubated with Fura2-AM
(2 µM) for 20 min at room temperature and stimulated with 200 µM of Carbachol (CCh) to induce the release of Ca2+ from the ER to the cytosol via activation of IP3R (B)
The graph shows mean traces of [Ca2+]cyto expressed in nM (WT, n  3/64; preparations/cells; Opa1−/−, n  3/87; Opa1−/− + OPA1 WT, n  3/100) (C) Mean traces
of [Ca2+]mito. (D,E) Maximal [Ca2+]cyto and [Ca2+]mito amplitude upon agonist stimulation. (F) The graph shows mean traces of [Ca2+]mito uptake vs IP3R-induced
(Continued )
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FIGURE 1 | [Ca2+]cyto release. (G) [Ca2+]cyto at which WT, Opa1−/−, and +OPA1 WT shows 2 fold increase in [Ca2+]mito upon CCh stimulation. (H) ER-independent
mitochondrial Ca2+ uptake, schematic experimental design. Prior to stimulation with CCh, cells were washed and kept in Ca2+-free medium. In order to completely
deplete Ca2+ from the ER, we ﬁrst induced the stimulation of IP3R by CCh 200 µM (60s), followed by 2 µM of Thapsigargin (Tg) (200s). Finally, SOCE was triggered by
1 mM CaCl2 addition. (I) The graph shows mean traces of [Ca2+]cyto after CaCl2 addition (WT, n  3/78; preparations/cells; Opa1−/−, n  3/84; Opa1−/− + OPA1 WT, n 
3/74). (J) [Ca2+]mito mean traces upon CaCl2 addition. (K,L) Maximal [Ca2+]cyto and [Ca2+]mito amplitude upon SOCE induction. (M) The graph shows mean traces of
[Ca2+]mito uptake vs SOCE-linked [Ca2+]cyto. (N) [Ca2+]cyto at which WT, Opa1−/−, and +OPA1 WT shows 1.5 fold increase in [Ca2+]mito upon SOCE induction. (O) Cells
were incubated with TMRM 20 nM and stimulated as described above. The bar graph shows resting Δψm calculated a s the subtraction between initial ﬂuorescence and
ﬂuorescence after FCCP addition (WT, n  3/63; preparations/cells; Opa1−/−, n  3/105; Opa1−/− + OPA1 WT, n  3/113). (P) Upper panel: TEM analysis of ERmitochondria contacts of WT and Opa1−/− cells, representative images (ER is pseudo-colored in blue). Bottom panel: Quantiﬁcation of ER-mitochondria distance
≤30 nm (WT, n  3/103; preparations/mitochondria; Opa1−/−, n  3/99). (Q) Upper panel: TEM analysis of ER-mitochondria contacts of Opa1−/− and Opa1−/− + OPA1
WT stable MEFs cells, representative images (ER is pseudo-colored in blue). Bottom panel: Quantiﬁcation of ER-mitochondria distance ≤30 nm (Opa1−/−, n  2/90;
preparations/mitochondria; Opa1−/− + OPA1 WT, n  2/100). Data are mean ± SEM. Error bar represent SEM. (*p < 0.05vs. WT, **p < 0.01 vs. WT, ***p < 0.001 vs. WT,
****p < 0.0001 vs. WT, ###p < 0.001 vs. Opa1−/− cells).

protein, mtRCaMP was expressed to monitor the [Ca2+] mito
simultaneously with [Ca2+] cyto tracked by a Ca2+ sensing dye,
Fura2-AM. The cells were also transfected with the muscarinic
type 3 receptor (M3R) to allow Carbachol (CCh)-induced [Ca2+]
2+
cyto transients through activation of IP3R-mediated Ca
mobilization from the ER (Figure 1A).
First, we explored the differences in the Ca2+ signaling
between WT and Opa1−/− cells. Our data showed lower
resting [Ca2+]cyto levels (50.2 ± 2.9 nM) in Opa1−/− cells
compared with WT cells (127.8 ± 7.8 nM), and upon the acute
rescue with the human OPA1 isoform 1 (OPA1), we found a
partial restoration of the baseline (83.6 ± 5.2 nM, Supplementary
Figure S1A). After CCh stimulation, we observed lower maximal
[Ca2+]cyto amplitude in Opa1−/− cells (333.6 ± 21.4 nM) compared
with WT cells (775.9 ± 47.6 nM). Moreover, the exogenous
expression of OPA1 partially rescued the [Ca2+]cyto signal
(544.6 ± 25.8 nM, Figures 1B,D).
The resting [Ca2+]mito was elevated in Opa1−/− cells. This was
also detected by an alternative Ca2+
mito sensor, mtCEPIA3. In
addition, OPA1 rescue further increased resting [Ca2+]mito,
suggesting that acute restoration of OPA1 to mitochondria is
insufﬁcient to lower basal [Ca2+]mito to WT levels
(Supplementary Figures S1B–E). The baseline-normalized
agonist-stimulated [Ca2+]mito transients showed no differences
between WT and Opa1−/− cells, whereas the OPA1-rescued MEFs
showed an increased [Ca2+]mito (Figures 1C,E). Interestingly,
after reaching the maximum [Ca2+]mito amplitude, Opa1−/− cells
exhibited faster decay kinetics than WT cells, however, this decay
in the [Ca2+]mito is not rescued by acute expression of OPA1.
To further explore the correlation between [Ca2+]mito, and
IP3-linked Ca2+ release, the two variables were plotted against
each other (Figure 1F). The graph shows that Opa1−/− cells
needed less [Ca2+]cyto to induce Ca2+
mito uptake than WT cells,
which can be partially rescued by the expression of OPA1
(Figure 1G). To test the possibility of mitochondrial Ca2+
uptake capacity saturation, we plotted the maximal [Ca2+]mito
vs the maximal [Ca2+]cyto in single WT cells. As shown in
Supplementary Figure S1F, there is a positive correlation
between the [Ca2+]cyto peak and the [Ca2+]mito peak,
conﬁrming that the mitochondrial Ca2+ uptake or the Ca2+
sensor was not saturated in the range of the responses.
Moreover, lower [Ca2+]cyto was needed to induce maximal
[Ca2+]mito (Supplementary Figure 1G). In summary, the
[Ca2+]cyto records indicate lesser ER Ca2+ content/release,
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whereas the [Ca2+]mito -[Ca2+]cyto relationship seems to
support more effective decoding of the IP3R-mediated Ca2+
release by mitochondrial Ca2+ uptake in Opa1 deﬁcient cells
than that in the control cells.
To evaluate the ER Ca2+ content/release, in a Ca2+ free
extracellular medium, we stimulated the cells with
Thapsigargin (2 µM) to discharge ER Ca2+ by blocking the
ER-Ca2+ re-uptake through the Sarcoendoplasmic Reticulum
Calcium-ATPase (SERCA). To follow the Ca2+ that the
the cells were
mitochondria face upon Ca2+
ER release,
transfected with an outer mitochondrial membrane-targeted
Ca2+ sensor (OMMRCaMP). Both [Ca2+]cyto and [Ca2+]OMM
responses showed a decreased Ca2+ release from ER
(Supplementary Figures S1H–K), suggesting that the free
−/−
cells and this is not
Ca2+
ER content is attenuated in the Opa1
reverted by the acute expression of OPA1.
To further test the ER Ca2+ content, in a Ca2+ free extracellular
medium, we ﬁrst stimulated the cells with CCh to induce IP3Rmediated release of Ca2+ from the ER, and then, we added
Thapsigargin to discharge the residual ER Ca2
(Supplementary Figure S1L). The [Ca2+]cyto responses
conﬁrmed that ER Ca2+ content is reduced in the Opa1−/−
cells than that in the WT. Acute expression of OPA1 failed to
rescue the ER Ca2+ content. (Supplementary Figures S1M,N).
During CCh stimulation, mostly local ER-to-mitochondria
Ca2+ transfer mediates the [Ca2+]mito rise. To test if the [Ca2+]mito
increase induced by a bulk [Ca2+]cyto increase is also altered in the
Opa1-deﬁcient cells, Store Operated Calcium Entry (SOCE) was
induced by adding 1 mM CaCl2 after the ER Ca2+ depletion
(Figure 1H; Supplementary Figure S1L). After SOCE induction,
Opa1−/− cells showed an augmented [Ca2+]cyto transient
amplitude (790.7 ± 44.2 nM) compared with WT cells
(629.4 ± 44.5 nM), and this effect was completely rescued
upon OPA1 expression (525.1 ± 40.0 nM, Figures 1I,K). The
corresponding [Ca2+]mito responses were slightly but signiﬁcantly
augmented in Opa1−/− cells compared with WT but similar to
that in the OPA1 rescued cells (Figures 1J,L). However, plotting
[Ca2+]mito vs. [Ca2+]cyto revealed higher [Ca2+]cyto requirement to
induce [Ca2+]mito in Opa1−/− cells than WT or rescued cells
(Figures 1M,N; Supplementary Figure S1O). Thus, Opa1−/−
cells have an advantage in the mitochondrial response to
IP3R-mediated Ca2+ release from the ER but they have a
disadvantage in the response to the SOCE-mediated global
[Ca2+]cyto increase.
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To test if some of the differences between WT, Opa1−/−, and
rescued cells might result from a difference in the driving force for the
mitochondrial Ca2+ uptake, we studied mitochondrial membrane
potential (Δψm) by a potentiometric dye, TMRE. Consistent with
Fülop et al (Fülöp et al., 2011), we found that Opa1−/− cells exhibited
lower resting Δψm than WT cells, which was partially rescued by
OPA1 (Figure 1O). This might be a reason for the relatively weak
[Ca2+]mito response by the Opa1−/− cells to the enhanced SOCE.
We next tested if a difference in the mitochondrial mass or
mtCU abundance/composition might explain the differential
[Ca2+]mito responses in the Opa1−/− cells and the controls. We
found that both, Opa1−/− and OPA1 rescued cells exhibit elevated
levels of mitochondrial mass markers (Supplementary Figures
S2A,B). We also found that Opa1−/− MEFs showed no changes in
the main mtCU components after mitochondrial mass
normalization (Supplementary Figures S2C,D).
Finally, we tested the ER-mitochondrial spatial relationship and
mitochondrial ultrastructure as a potential source of the differences in
the [Ca2+]mito responses by transmission electron microscopy (TEM).
Our results showed IMM topology perturbation and cristae
compartmentalization in the Opa1−/− MEFs, as previously
described (Frezza et al., 2006; Olichon et al., 2007a). Furthermore,
we found signiﬁcantly closer ER-mitochondria gaps in Opa1−/− cells,
compared with WT cells (Opa1−/−:15.71 ± 0.41 nm vs. WT: 17.92 ±
0.38 nm) (Figure 1P). To test the OPA1-speciﬁcity of our ﬁndings, we
generated Opa1−/− + OPA1 WT stable MEF cells (Supplementary
Figure S2E) and tested the ER-mitochondrial distance. We found
increased ER-mitochondria distance in OPA1 rescued cells compared
with Opa1−/− cells (Opa1−/− + OPA1: 17.81 ± 0.67 nm vs. Opa1−/−:
14.98 ± 0.72) (Figure 1Q).
Thus, we conclude that the lack of Opa1 causes multiple
2+
changes in the Ca2+
cyto and Camito homeostasis including an
2+
attenuated ER Ca storage and enhanced SOCE. Still, the
2+
release is
Ca2+
mito uptake response to IP3R-mediated Ca
enhanced, likely because of closer physical proximity between
mitochondria and the ER.

c.2818+5G>A mutations, exhibited lower OPA1 protein levels
compared with Control cells or the c.2713C>T mutant
(Figure 2B; Supplementary Figure S3A).
To evaluate intracellular Ca2+ signaling, we ﬁrst measured
resting [Ca2+]. Our results showed that patients’ cells have
unaltered resting [Ca2+]cyto (Figures 2C,D; Supplementary
Figure S3B). Analysis of Ca2+
mito showed no differences in
[Ca2+]mito resting in patients’ cells carrying GTPase mutants.
However, the GED mutant c.2713C>T showed elevated resting
[Ca2+]mito compared with control patient cells (Supplementary
Figure S3C).
Then, we used histamine as an agonist to induce Ca2+ release
from the ER through activation of the IP3R. Data in Figures 2C,D
show that the patients’ cells displayed comparable maximal
[Ca2+]cyto transient amplitude than control individuals. Cells
carrying GTPase mutations showed no signiﬁcant changes in
[Ca2+]mito rise; however, cells carrying the GED mutant
c.2713C>T displayed lower [Ca2+]mito increase compared with
control cells (Figures 2E,F). [Ca2+]mito vs.[Ca2+]cyto chart showed
that all the ADOA patient’s cells had a leftward shift tendency in
this relationship compared to control cells (Figures 2G,H;
Supplementary Figure S3D).
Next, we evaluated the resting Δψm in ADOA-derived cells.
Fibroblast carrying GTPase mutants showed no signiﬁcant
changes, but GED mutant c.2713C>T exhibited a higher
resting Δψm compared with control cells, which may be a
factor in the elevated resting [Ca2+]mito levels and therefore,
reduced [Ca2+]mito transients amplitude (Figure 2I).
Finally, we tested the distance between the ER and the
mitochondria. EM analysis of ADOA-derived ﬁbroblasts revealed
that cells carrying the GTPase mutants c.889C>T, c.870+5G>A and
the GED mutant c.2818+5G>A exhibited signiﬁcantly closer ERmitochondria apposition, compared with control cells (Skin Control:
20.24 ± 0.35 nm, OPA1 c.889C>T 16.6 ± 0.35 nm, SkM Control:
20.3 ± 0.39 nm, OPA1 c.870+5G>A 17.93 ± 0.49 nm, OPA1
c.2818+5G>A 18.09 ± 0.38 nm). Yet, we found no differences
between control and GED mutant c.2713C>T carrying cells
(Figure 2J; Supplementary Figure S3E). Strikingly, all the
samples that exhibited closer ER-mitochondria contacts also
displayed lower OPA1 protein levels (Figure 2B).
In summary, ADOA-derived ﬁbroblasts showed no defects on
[Ca2+]cyto transients unlike Opa1−/− cells. However, we found that
2+
all the studied mutants needed lesser Ca2+
cyto to trigger a Camito rise,
−/−
consistent with the observations in Opa1 cells. Interestingly,
the patients’ cells showed a correlation between OPA1 protein
levels and ER-mitochondria distance. Thus, despite the distinct
severities of ADOA disease, caused by GTPase and GED mutants,
both kinds of aberrant proteins lead to similar Ca2+ homeostasis
dysregulation.

Mitochondrial Ca2+ Homeostasis, ΔΨm, and
ER-Mitochondria Contacts Are Altered in
ADOA-Derived Patient Cells Carrying OPA1
Domain-speciﬁc Mutations
We wanted to address if ADOA patient-derived ﬁbroblasts
carrying domain-speciﬁc heterozygous OPA1 mutations
replicate the defects in Ca2+ homeostasis and ER-mitochondria
distance Opa1−/− cells exhibited. Fibroblasts carrying speciﬁc
mutations at the GTPase domain included OPA1 c.870+5G>A,
with a deletion of the Exon8, and c.889C>T with an early stop
codon at GTPase domain. Both patients presented a severe form
of the disease, involving other symptoms besides optic nerve
atrophy, known as ADOA+ (MIM# 125250). Also, we studied
patients carrying speciﬁc mutations in GED: OPA1 c.2713C>T
leading to a stop codon and loss of the GED domain, and
c.2818+5G>A with a deletion of GED coding exon 27. These
patients presented symptoms restricted to the eye or plain ADOA
(MIM#165500) (Figure 2A). Western blot analysis revealed that
patients’ cells carrying c.889C>T, c.870+5G>A, and
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OPA1 GED Domain Determines Functional
ER-to-Mitochondrial Coupling
Given that patients’ cells might carry genetic or environmental
adaptations, we next studied the domain-speciﬁc effects of OPA1
mutants in an Opa1−/− background. For this, we generated
ADOA-causing OPA1 GTPase and GED domain-speciﬁc
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FIGURE 2 | Mitochondrial Ca2+ homeostasis, mitochondrial membrane potential, and ER-mitochondria distance are altered in cells from ADOA patients carrying
OPA1 domain-speciﬁc mutations. (A) OPA1 disease-related mutations, protein product prediction, type of mutation, and clinical ADOA phenotype, evaluated in this
study. (B) Western blot analysis of OPA1 protein abundance of the skin or skeletal muscle-derived ﬁbroblasts from ADOA patient’s cells. (C) Skin or skeletal muscle
ADOA-derived ﬁbroblast expressing mtRCaMP were loaded with Fura2-AM (2 μM) for 20 min at room temperature. To induce the release of Ca2+ through IP3R
activation, Histamine 100 μM was used. The graph show [Ca2+]cyto expressed as Fura2-AM 340/380 mean ratio values (Skin Control, n  3/12; preparations/cells; Skin
OPA1c.889C>T, n  3/18; SkM Control, n  5/17, SkM OPA1c.870+5G>A, n  7/21; SkM OPA1c.2713C>T, n  4/19). (D) The bar chart shows maximal [Ca2+]cyto
amplitude upon agonist stimulation. (E) Mean traces of Skin or skeletal muscle ADOA-derived ﬁbroblast [Ca2+]mito upon Histamine stimulation. (F) The bar chart shows
maximal [Ca2+]mito uptake upon agonist stimulation expressed in F/F0 to mtRCaMP. (G) The graph shows mean traces of [Ca2+]mito uptake vs IP3R-induced [Ca2+]cyto
release. (H) [Ca2+]cyto at which WT, Opa1−/−, and +OPA1 WT shows 1.4 fold increase in [Ca2+]mito upon agonist stimulation. (I) Skin or skeletal muscle ﬁbroblasts from
ADOA-patients were loaded with TMRM 10 nM and Fura2-AM. Incubation and stimulation were performed as described above. At the end of the experiment, FCCP
10 µM was added to dissipate me membrane potential. The bar chart shows resting Δψm. (Skin Control, n  3/25; preparations/cells; Skin OPA1c.889C>T, n  3/18;
SkM Control, n  3/25, SkM OPA1c.870+5G>A, n  3/25; SkM OPA1c.2713C>T, n  3/28) (J) ER-mitochondria distance analysis for all mitochondria with ER contact
(Continued )
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FIGURE 2 | (≤30 nm distance) (Skin control, n  2/96; preparations/mitochondria), (OPA1c.889C>T, n  2/101), (SkM control, n  3/106), (OPA1c.870+5G>A, n  3/
120), (OPA1c.2713C>T, n  3/123), (OPA1c.2818+5G>A, n  2/92). p-values for Skin ﬁbroblasts were calculated by Mann-Whitney U-test. p-values for SkM ﬁbroblasts
were calculated using Kruskal-Wallis test. Data are mean ± SEM. Error bar represent SEM. *p < 0.05, **p < 0.01, ***p < 0.001 vs respective control condition The blue
color is indicative of GTPase mutants and the red color for GED mutants.

SOCE induction, the augmented [Ca2+]cyto transients of the
Opa1−/− cells were restored by WT OPA1. All the mutants
also displayed [Ca2+]cyto transients comparable with WT OPA1
(Figures 3J–L). However, no signiﬁcant effect was observed on
[Ca2+]mito upon SOCE induction in Opa1−/− or rescued cells
(Figures 3M–O).
A two-variable chart was plotted to explore the role of bulk
2+
Ca2+
cyto entry on ER-independent Camito uptake. The graphs show
2+
−/−
that upon [Ca ]cyto increase, Opa1 cells exhibited a rightward
shift in [Ca2+]cyto needed to induce [Ca2+]mito rise, compared with
the GTPase or GED mutants (Figures 3P–R). Moreover, Opa1−/−
mitochondria required 790.7 ± 44.2 nM of [Ca2+]cyto to reach the
maximal [Ca2+]mito, and this was completely restored with the
inclusion of either OPA1 or the mutants, requiring lower
[Ca2+]cyto to reach the maximal [Ca2+]mito (Supplementary
Figure S4G).
Next, we measured resting Δψm to test if the driving force of
Ca2+ uptake is altered upon the expression of some of the OPA1
mutants. No change in resting Δψm was detected in the GTPase
mutant c.870+5G>A (Figure 3S). We found the GED mutant
c.2713C>T exhibited an augmented resting Δψm compared with
OPA1 WT rescue (Figure 3S), as we observed in the patient cells
harboring the same mutant (Figure 2I). Thus, although WT and
GTPase OPA1 mutants can restore ER-to-mitochondrial Ca2+
transfer, this seems independent of the cation driving force
evoked by Δψm. Finally, Mcu protein levels were unaltered by
the acute expression of neither OPA1 GTPase nor GED mutants
(Figure 3T).
Thus, OPA1 GED region plays a critical role in ERmitochondrial Ca2+ transfer, and this effect is independent of
resting Δψm, OPA1, or Mcu protein levels. Moreover, Ca2+
mito
uptake induced by bulk Ca2+
cyto was restored by OPA1 or the
mutants suggesting that the sole physical presence of the protein
is sufﬁcient to support this process, in a domain-speciﬁc
independent manner.

mutants, matching the patients’ genotype (Supplementary
Figure S4A). We observed that different mutants show
distinct protein levels, consistent with our observation in the
patients’ cells (Figure 2A). Particularly, mutants carrying splicing
defects, such as OPA1 c.870+5G>A and c.2818+5G>A, display
lower protein levels than WT OPA1, suggesting defects in protein
stability.
Our data showed that the acute expression of WT OPA1
rescues decreased resting [Ca2+]cyto levels shown by Opa1−/− cells;
nevertheless, the expression of each ADOA-causing OPA1
mutants displayed resting [Ca2+]cyto levels comparable to
Opa1−/− cells. These data suggest that OPA1 integrity is
critical to support a mitochondrial role in the Ca2+
cyto balance
under non-stimulated conditions (Figures 3A,B; Supplementary
Figure S4B). The analysis of Ca2+
mito showed that all studied OPA1
GED mutants exhibited increased resting [Ca2+]mito
(Supplementary Figures S4C–E). Consistently, we observed
the same effect in the Opa1−/− cells and the OPA1 GED
mutation c.2713C>T patient cells (Supplementary Figures
S1A, S3C, respectively), suggesting that the GED region, and
not the GTPase domain, may play a speciﬁc role in the regulation
of [Ca2+]mito resting levels.
Upon CCh stimulation, both WT and OPA1 GTPase
mutants rescued the maximal [Ca2+]cyto rise; whereas, GED
domain mutants showed no rescue (Figures 3A–C). In terms
of maximal [Ca2+]mito transient amplitude triggered by CCh,
neither the acute expression of WT OPA1 nor the OPA1
mutants, showed a signiﬁcant difference compared to
Opa1−/− cells (Figures 3D–F). This might be a consequence
of a chronic absence of Opa1 or alternatively, more than one
OPA1 isoform is needed to restore Ca2+
mito homeostasis, as it has
been demonstrated for mitochondrial network morphology
(Del Dotto et al., 2017).
We next studied the correlation between ER-associated
[Ca2+]mito and [Ca2+]cyto responses. Our data showed that as in
Opa1−/− background, the expression of OPA1 GED mutants,
displayed a leftward shift in [Ca2+]cyto needed to induce a
[Ca2+]mito rise compared with WT or GTPase rescued
conditions (Figures 3G–I). Moreover, the levels of [Ca2+]cyto
needed to generate the maximal [Ca2+]mito were rescued by the
OPA1 GTPase mutants, while OPA1 mutants lacking GED
displayed only a mild rescue (Supplementary Figure S4F).
Thus, our data suggest that Ca2+ transfer to the mitochondria
from local Ca2+
cyto is enhanced when the GED region or the entire
protein is missing. However, this asseveration doesn’t totally match
with the GTPase mutant c.889C>T, which expresses a truncated
protein form due to a stop codon (Figure 2A) and showed a
behavior comparable to the GTPase mutants rather than the GED
mutants.
To test the OPA1 domain-speciﬁc effects on the Ca2+
mito rise
prompted by bulk Ca2+
cyto increases, we turned to SOCE. Upon
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Overexpression of OPA1 Mutants impairs
Ca2+ Homeostasis
Considering the heterozygosity of the ADOA patients carrying
OPA1 mutations, we tested if the introduction of OPA1 mutants,
in the presence of native Opa1 in the WT MEF background,
disrupts normal Ca2+ homeostasis like what was observed in the
patient cells.
Our results showed that acute expression of OPA1 mutants did
not alter resting [Ca2+]cyto (Supplementary Figure S4H).
Interestingly, the GTPase mutant c.1334G>A exhibited a high
resting [Ca2+]mito when compared with WT OPA1
overexpression (Supplementary Figures S4I–K).
Upon CCh stimulation, we found a decreased maximal
[Ca2+]cyto amplitude in the GTPase mutant c.1334G>A when
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FIGURE 3 | OPA1 GED domain is required effective ER-to-mitochondrial Ca2+ transfer. (A,B) ER-dependent Ca2+ release. Opa1−/− MEF cells expressing OPA1 mutants,
mtRCaMP, and the muscarinic receptor 3 (M3R), were incubated with Fura2-AM as described, and stimulated with 200 µM of Carbachol (CCh) to induce the release of Ca2+ from
the ER to the cytosol via activation of IP3R. Graph show mean traces of [Ca2+]cyto expressed in nM. (A) Shows mean traces of GTPase mutants and (B) shows mean traces of GED
mutants of [Ca2+]cyto transients, respectively (Opa1−/− MEF, n  3/87; Opa1−/− + OPA1 WT, n  3/100; Opa1−/− + OPA1c.870+5G>A, n  3/100; Opa1−/− + OPA1c.889C>T, n 
3/55; Opa1−/− + OPA1c.1334G>A, n  3/35; Opa1−/− + OPA1c.2708delTTAG, n  3/69; Opa1−/− + OPA1c.2713C>T, n  3/109; Opa1−/− + OPA1c.2818+5G>A, n  3/55). (C) The
(Continued )
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FIGURE 3 | bar chart shows maximal [Ca2+]cyto amplitude upon agonist stimulation. (D,E) The graph shows mean traces of [Ca2+]mito uptake for OPA1 GTPase and GED
mutants. (F) Maximal [Ca2+]mito uptake induced upon agonist stimulation. (G,H) OPA1 GTPase and GED mutants [Ca2+]mito uptake vs IP3R-induced [Ca2+]cyto upon
agonist stimulation. (I) [Ca2+]cyto at which OPA1 GTPase and GED mutants shows 2 fold increase in [Ca2+]mito upon agonist stimulation. (J,K) ER-independent Ca2+
transients; SOCE. Opa1−/− MEF cells expressing hOPA1 mutants, mtRCaMP, and the muscarinic receptor 3 (M3R), were incubated with Fura2-AM as described above.
Prior stimulation with CCh, cells were washed and kept in a Ca2+ free medium. To induce the stimulation of IP3R, cells were treated with CCh 200 µM, followed with 2 µM
of Thapsigargin (Tg) to completely deplete the Ca2+ from the ER. Then, 1 mM of CaCl2 was added to induce the SOCE. Graph show mean traces of [Ca2+]cyto expressed
in nM upon SOCE induction for GTPase and GED mutants (Opa1−/− MEF, n  3/84; Opa1−/− + OPA1 WT, n  3/74; Opa1−/− + OPA1c.870+5G>A, n  3/50; Opa1−/− +
OPA1c.889C>T, n  3/35; Opa1−/− + OPA1c.1334G>A, n  3/47; Opa1−/− + OPA1c.2708delTTAG, n  3/38; Opa1−/− + OPA1c.2713C>T, n  3/54; Opa1−/− +
OPA1c.2818+5G>A, n  3/36). (L) Maximal [Ca2+]cyto amplitude upon SOCE induction. (M,N) Mean traces of [Ca2+]mito uptake upon SOCE induction. (O) Maximal
[Ca2+]mito uptake upon SOCE induction. (P,Q) The graphs show [Ca2+]mito uptake vs SOCE-linked [Ca2+]cyto. (R) [Ca2+]cyto at which OPA1 GTPase and GED mutants
shows 1.5 fold increase in [Ca2+]mito upon SOCE induction. (S) Same cells described in A were incubated with TMRM 20 nM and stimulated as described above. The bar
graph shows resting Δψm calculated as the subtraction between initial ﬂuorescence and ﬂuorescence after FCCP addition (Opa1−/− MEF, n  3/105; Opa1−/− + OPA1
WT, n  3/113; Opa1−/− + OPA1c.870+5G>A, n  3/103; Opa1−/− + OPA1c.2713C>T, n  3/73). (T) Western blot analysis of Mcu protein abundance upon acute
expression of OPA1 GTPase or GED mutants in Opa1−/− MEF cells. Data are mean ± SEM. Error bars represent SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
vs. Opa1−/− condition. #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001 vs. Opa1−/− + OPA1 WT condition. The blue color is indicative of GTPase mutants and the red
color for GED mutants.

is compared with WT OPA1 overexpression (Figures 4A–C). The
same mutant exhibited an elevated maximal [Ca2+]mito transient
amplitude upon agonist stimulation (Figures 4D–F). In addition,
GED mutant c.2818+5G>A exhibited a reduced maximal
[Ca2+]cyto amplitude after agonist stimulation compared to
WT OPA1 overexpression (Figure 4C). Moreover, both GED
mutants c.2713C>T and c.2818+5G>A displayed a reduced
[Ca2+]mito (Figure 4F). The same reduction in [Ca2+]mito was
observed in the ADOA patient’s cells carrying the GED mutant
c.2713C>T.
Correlative study of [Ca2+]mito and [Ca2+]cyto transients
showed that overexpression of OPA1 WT displayed no
alteration in the [Ca2+]cyto needed to trigger a [Ca2+]mito rise.
In contrast, the acute expression of most GTPase or GED
mutants, prompted a leftward shift in [Ca2+]cyto needed to
induce [Ca2+]mito rise upon agonist stimulation (Figures
4G–I). Consistently, as oppose to WT OPA1 overexpression,
the inclusion of GTPase or GED mutants lowered the maximal
[Ca2+]cyto needed to evoke maximal [Ca2+]mito (Supplementary
Figure S4L).
Evaluation of Δψm revealed that acute overexpression of OPA1
WT decreased resting Δψm (Figure 4J). Yet, neither GTPase
mutant c.870+5G>A nor GED mutant c.2713C>T
overexpression altered resting Δψm in a WT MEF background.
(Figure 4J). Finally, we found no differences in Mcu protein levels
caused by WT or mutant OPA1 overexpression (Figure 4K).
Thus, acute expression of ADOA-causing OPA1 mutants in
the presence of endogenous Opa1 causes a dominant-negative
phenotype in ER-to-mitochondria Ca2+ transfer.

negative phenotype independent of the domain affected by the
speciﬁc mutation possibly, contributing to ADOA disease
progression (Figure 4L; Supplementary Table S1).
In different cell types, the absence of OPA1 has shown diverse
results. In cultured RGCs, the principal cells affected by OPA1
mutants causing DOA (Votruba et al., 1998), silencing of Opa1
augmented Ca2+
cyto transients (Dayanithi et al., 2010; Kushnareva
et al., 2013). Interestingly, RGCs expressing OPA1 ADOAcausing mutants, show elevated Ca2+
cyto (Zaninello et al., 2021).
However, proopiomelanocortin neurons devoid of Opa1 show
2+
unaltered Ca2+
cyto transients, and reduced Camito responses
(Gómez-Valadés et al., 2021). Finally, adult cardiomyocytes of
Opa1+/− mice displayed lower [Ca2+]cyto amplitude (Chen et al.,
2012; Le Page et al., 2016) or enhanced Ca2+
mito uptake (Piquereau
et al., 2012). These studies suggest that OPA1 affects intracellular
Ca2+ homeostasis, possibly, in a cell-type speciﬁc manner.
Our data in Opa1−/− cells exhibited alterations in cytosolic, ER
and mitochondrial Ca2+ homeostasis. Resting [Ca2+]cyto was
reduced in Opa1−/−, which could be explained by a decreased
inﬂux or increased efﬂux of Ca2+. The former is unlikely because a
higher inﬂux was detected upon SOCE, whereas, the latter is not
consistent with our Δψm data, which suggests lower ATP levels in
these cells. Also, CCh-induced [Ca2+]cyto transient amplitude was
decreased in Opa1−/− cells, caused by lower ER content, suggesting
that chronic absence of Opa1 leads to an adaptation in ER Ca2+
homeostasis, that could involve IP3R or SERCA levels or activity
alterations. Moreover, resting and maximal [Ca2+]mito was
augmented despite low resting Δψm during local Ca2+ transfer.
This observation is consistent with previous reports in OPA1
silenced intact HeLa and H295R cells using a genetically encoded
Ca2+
mito sensor (Fülöp et al., 2011). Conversely, another group
reported OPA1 silencing decreases maximal [Ca2+]mito amplitude
upon Histamine stimulation, using Rhod-2 as a Ca2+
mito sensor in
intact cells (Kushnareva et al., 2013). These opposite results can be
attributed to the different technical approaches. The mitochondriaspeciﬁc nature of [Ca2+]mito transients studied by genetic encoded
Ca2+-sensitive proteins, provides strong pieces of evidence to
conﬁrm that both acute (Fülöp et al., 2011), and chronic absence
of OPA1 studied in this work lead to augmented Ca2+
mito uptake.
Hence, our study strengths the idea of OPA1 as a key molecular
modulator in ER-to-mitochondria Ca2+ transfer.

DISCUSSION
We showed here that cells with low levels of Opa1 exhibit closer
ER-mitochondria apposition, likely resulting in a more efﬁcient
ER-to-mitochondria Ca2+ transfer. This occurs without changes
in the mtCU components or mitochondrial mass, and despite the
reduced resting Δψm presented by the Opa1-deﬁcient cells. In an
Opa1-null background, ADOA-causing mutants located in OPA1
2+
GED region perturbed ER-dependent Ca2+
cyto transients and Camito
uptake. In WT background, OPA1 mutants evoke a dominant-
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FIGURE 4 | Overexpression of ADOA-causing OPA1 mutants impairs ER-to mitochondrial Ca2+ transfer. (A,B) WT MEF cells expressing OPA1 mutants,
mtRCaMP, and the muscarinic receptor 3 (M3R), were incubated with Fura2-AM and stimulated with 200 µM of Carbachol (CCh) to induce the release of Ca2+ from the
ER to the cytosol via activation of IP3R. Graph show mean traces of [Ca2+]cyto expressed in nM, in WT MEF expressing GTPase and (B) in GED mutants (WT MEF, n  3/
64; WT + OPA1 WT, n  3/58; WT + OPA1c.870+5G>A, n  3/49; WT + OPA1c.889C>T, n  3/48; WT + OPA1c.1334G>A, n  3/51; WT + OPA1c.2708delTTAG,
n  3/47; WT + OPA1c.2713C>T, n  3/49; WT + OPA1c.2818+5G>A, n  3/42) (C) Bar chart shows maximal [Ca2+]cyto amplitude upon agonist stimulation. (D,E) The
(Continued )
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FIGURE 4 | graph shows mean traces of [Ca2+]mito uptake in OPA1 GTPase and GED mutants, expressing WT MEF cells. (F) Maximal [Ca2+]mito uptake induced upon
agonist stimulation. (G,H) OPA1 GTPase and GED mutants [Ca2+]mito uptake vs IP3R-induced [Ca2+]cyto upon agonist stimulation. (I) [Ca2+]cyto at which OPA1 GTPase
and GED mutants shows 2 fold increase in [Ca2+]mito. (J) The same cells described in A were incubated with TMRM 20 nM and stimulated as described by Carbachol.
The bar graph shows resting Δψm calculated as the subtraction between initial ﬂuorescence and ﬂuorescence after FCCP addition (WT MEF, n  3/63; WT + OPA1 WT,
n  3/117; WT + OPA1c.870+5G>A, n  3/159; WT + OPA1c.2713C>T, n  3/117; WT). (K) Western blot analysis of Mcu protein abundance upon acute expression of
OPA1 GTPase or GED mutants in WT MEF cells. Data are mean ± SEM. Error bar represent SEM. *p < 0.05, **p < 0.01 vs. WT condition. #p < 0.05, ##p < 0.01 vs. WT +
OPA1 WT condition. The blue color is indicative of GTPase mutants and the red color for GED mutants. (L) Working model. Cells lacking OPA1 exhibited closer ER2+
transfer. OPA1 ADOA-causing
mitochondria contacts and a leftward shift in Ca2+
cyto dependence compared to WT cells evoking a more efﬁcient ER-to-mitochondrial Ca
mutants disrupt Ca2+ homeostasis inducing an OPA1 dominant-negative phenotype, probably contributing to disease progression.

The reduced [Ca2+]cyto needed to induce a [Ca2+]mito rise shown
by Opa1−/− cells likely reﬂects enhanced ER-to-mitochondria
privileged communication, which might be caused by the
increased proximity between both organelles. Yet, this was
independent of resting mitochondrial Δψm and mtCU protein
levels. RNA-seq data has shown that mtCU components
expression levels were unaltered in Opa1 KO lymphocytes
(Corrado et al., 2021). In addition, silencing of Micu1 increases
resting matrix [Ca2+]mito (Mallilankaraman et al., 2012; Liu et al.,
2016; Gottschalk et al., 2019), as we observe in Opa1−/− cells. Given
that Opa1 can physically interact with Mcu-Micu1 complex
(Tomar et al., 2019; Herkenne et al., 2020), it remains possible
that the absence of Opa1 might alter Micu1 homo or
heterodimerization with Micu2, which have been proposed to
control Ca2+
mito uptake threshold (Patron et al., 2014). Also, it has
been suggested that loss of cristae junction can expose a population
of mtCU that is not protected by the gatekeeper Micu1 in the cristae
lumen (Gottschalk et al., 2019), this explanation could justify the
increased resting a maximal Ca2+
mito observed in the Opa1 KO cells.
However, this explanation would not be consistent with a lack of
leftward shift in the [Ca2+]mito rise during SOCE.
How does OPA1 inﬂuence ER-mitochondrial Ca2+ transfer? It
has been shown that upon agonist stimulation, mitochondrial
cristae and matrix modify their volume in HepG2 cells (Booth
et al., 2016). Studies in HeLa cells proposed that OPA1
knockdown decelerates cristae membrane movements.
Interestingly, upon IP3R activation, cristae stop their motion
at the ER-mitochondria contact region, in an OPA1 independent
manner (Gottschalk et al., 2018). Thus, it remains a question
whether perturbation in OPA1 is connected to cristae dynamics
adaptations associated with Ca2+
mito uptake.
Regarding the role of OPA1 in Ca2+
mito uptake in response to
bulk Ca2+
cyto induced by SOCE, our data are opposed to previous
studies in HeLa and H295R OPA1 silenced cells performed in
permeabilized cells and depolarized mitochondria conditions
(Fülöp et al., 2011). These discrepancies can be attributed to
the experimental setting and the temporary vs. long-term OPA1
ablation conditions. As oppose to the cited work, our
experimental conditions involve polarized mitochondria and
chronic Opa1 ablation. In addition, we found that upon
SOCE, WT OPA1 rescue in Opa1−/− cells restored the Ca2+
cytodependence of the Ca2+
mito uptake even beyond that in the
WT cells. The exact restoration of the Ca2+
mito homeostasis in
the Opa1−/− cells likely requires more than one OPA1 isoforms, as
it has been demonstrated for mitochondrial morphology (Del
Dotto et al., 2017). Thus, we propose that OPA1 plays distinctive
roles in bulk versus ER-to-mitochondria-driven Ca2+
mito uptake.
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Our results showed that all the ADOA patients’ cells that
exhibited low levels of OPA1 displayed closer ER-mitochondria
contacts, independent of the mutated domain. In a previous study
in skin ﬁbroblast from patients carrying a splicing defect at the
GTPase domain, cells exhibited an enhanced Ca2+
mito uptake rate
(Fülöp et al., 2015). However, the GTPase mutants explored in
this study, both in patient’s cells and acutely expressed in MEFs,
displayed no changes in [Ca2+]mito. Interestingly, the previous
study found a high dispersion between patients carrying the same
mutation (Fülöp et al., 2015), suggesting that part of the effect
could be related to environmental adaptations or the patient’s
genetic background.
To isolate the domain-speciﬁc mutants’ effect we performed
in vitro studies in Opa1−/− background. We found that the
integrity of the whole OPA1 protein is necessary to restore
resting [Ca2+]cyto, given that neither GTPase nor GED mutants
altered resting [Ca2+]cyto. The GTPase domain was not required
to restore ER-dependent or ER-independent [Ca2+]mito uptake.
Previous studies have shown that GTPase is critical for
mitochondrial fusion activity (DeVay et al., 2009; Del Dotto
et al., 2017), suggesting that the OPA1 Ca2+ role can be
independent of the fusion activity. Instead, the GED mutants
couldn’t rescue resting or maximal [Ca2+]cyto, whereas, resting
but no maximal [Ca2+]mito was augmented. Elevated resting
[Ca2+]mito was also found in the patient’s cells harboring the
OPA1 GED mutant c.2713C>T, suggesting that this effect could
be speciﬁc for this domain. In addition, the GED mutants did not
restore the [Ca2+]cyto needed to induce [Ca2+]mito rise, suggesting
that the OPA1 GED domain is essential for the maintenance of
2+
resting Ca2+
mito and Camito uptake mediated by ER-mitochondria
2+
Ca transfer. OPA1 GED domain is a predicted coiled-coil
domain (Akepati et al., 2008); however, no molecular partner,
except for SIRT3, has been linked to physically interact with this
domain (Samant et al., 2014). Strikingly, GED mutant’s
expression restored bulk [Ca2+]cyto needed to induce [Ca2+]mito
rise, proposing that OPA1 GED domain could be relevant during
ER-mitochondria functional tethering through a, so far,
unknown molecular partner.
Finally, ADOA is a dominant disease, most of the patients are
heterozygous OPA1 mutant, with only a few reports of patients
with homozygous OPA1 mutations (MIM #605290). The
inclusion of OPA1 GTPase or GED mutants in the presence of
WT Opa1 in MEF cells, slightly diminished the Ca2+
mito uptake
without alteration of Mcu levels. A leftward shift in [Ca2+]cyto
dependence to promote [Ca2+]mito rise was a particular
characteristic observed in the Opa1−/− cells. Moreover, ADOA
patient cells exhibiting low levels of OPA1 displayed a closer ER-
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mitochondria distance, suggesting that OPA1 integrity and levels
are necessary for physiological intracellular Ca2+ regulation and
ER-mitochondria Ca2+ transfer. Thus, the cellular models studied
here, with patient cells and the acute expression of OPA1 mutants
in a WT background, all point towards a dominant-negative Ca2+
homeostasis phenotype, independent of the involved domain.
In conclusion, our study provides new evidence on a central
role for OPA1 in Ca2+ homeostasis and in determining functional
ER-mitochondrial coupling, with the GED region playing a
fundamental role in stabilizing the efﬁciency of inter-organelle
Ca2+ transfer. The co-existence of WT and ADOA-related
mutants could perturb ER-to-mitochondrial communication,
providing a mechanism for disease progression in patients
affected with ADOA disease.

MEFs were transfected with the mtRCaMP, the muscarinic
receptor type 3 (M3R), and OPA1 mutants. Forty-eight hours
after transfection the cells were incubated in a serum-free
extracellular medium (ECM: 121 mM NaCl, 5 mM NaHCO3,
10 mM Na-HEPES, 4.6 mM KCl, 1.2 mM KH2PO4, 1.2 mM
MgSO4, 2 mM CaCl2, 10 mM glucose, pH7.4) containing 2%
BSA and loaded with Fura2-AM (2 µM) in presence of 0.0003%
Pluronic F-127 and 100 μM sulﬁnpyrazone for 15 min at room
temperature. Cells were washed once with ECM containing 2%
BSA, and recorded in ECM containing 0.25% BSA, and
transferred to the thermostated stage (37°C) of the microscope.
Cells were stimulated by Carbachol (CCh) 200 nM to activate the
M3R, and subsequently, the IP3R, to induce Ca2+ release from the
ER. For SOCE, after Fura2-AM incubation, cells were washed
once with a Ca2+ free buffer. Imaging was performed in a Ca2+free ECM containing 0.25% BSA. Cells were stimulated by CCh
200 nM to activate the IP3R and induce Ca2+ release from the ER
and recorded for 150s, then the cells were stimulated with
Thapsigargin 2 µg to deplete the ER of Ca2+ and recorded for
300s, and ﬁnally, 1 mM of Ca2+ was added to induce SOCE.
Images were acquired using an ImagEM EM-CCD camera
(Hamamatsu) ﬁtted to an Olympus IX81 microscope with
LED source (Lambda TLED+, Sutter Instruments). The
conﬁguration for each ﬂuorescent probe or protein was as
follow: Fura2-AM was recorded using 340–380 nm excitation;
mtRCaMP was recorded with a 577 nm excitation ﬁlter;
CEPIA3mt was recorded using 485 nm excitation ﬁlter
(Chroma, customized 59022 UV ﬁlters), using dual-band
dichroic and emission ﬁlters (Chroma, 59022m dual-band
ﬁlters). Image collection frequency, 1 Hz. Calibration of the
Fura2-AM signal was carried out at the end of each
measurement, adding 1 mM CaCl2, followed by 10 mM
EGTA/Tris, pH 8.5. The Fura2-AM ratios were calibrated in
terms of nM [Ca2+]cyto using the following formula:

MATERIALS AND METHODS
Cell Culture
Experiments were performed in ﬁbroblasts derived from ADOA
patients and control individuals or WT and Opa1 KO Mouse
embryonic ﬁbroblasts (MEFs) (provided by David Chan). Patientderived cells were provided by Newcastle Research Biobank for
Rare and Neuromuscular Diseases, based on a Material
Transference Agreement with Pontiﬁcia Universidad Católica de
Chile, and were maintained following the institutional biosecurity
and bioethics protocols. All the cells were cultured in high glucose
Dulbecco-Eagle modiﬁed medium containing sodium pyruvate
(DMEM, Gibco Cat#1280017) and supplemented with 10% of
fetal bovine serum (FBS), 2 mM glutamine, and 100 U/ml
penicillin, and 100 μg/ml streptomycin in humidiﬁed air (5%
CO2) at 37°C. Given that human myoblasts grow slowly,
skeletal muscle-derived ﬁbroblasts were generated from
myoblast samples. Brieﬂy, the patient’s derived myoblasts were
cultured in Skeletal Muscle Cell Growth Medium (PromoCell
#CatC-23160) and plated in collagen I-coated dishes. Cells were
trypsinized and pre-plated in an uncoated dish for 30 min to
separate ﬁbroblasts from myoblasts, where the former adhere to
the uncoated dish while the latter were resuspended and placed
aside. The patient’s ﬁbroblasts were used between passages 3–9. All
the cells were tested for mycoplasma contamination regularly using
the following protocol (Young et al., 2010).

R − Rmin
F380
Ca2+ cyto (nM)  Kd Fura2AM × 
 ×  max

Rmax − R
F380
min
Where Fura2-AM Kd was 224 nM, R is ratio 340/380 nm, Rmin
is the ratio 340/380 after EGTA addition, Rmax is the ratio 340/
380 nm after 1 mM CaCl2 addition, Fmax is the maximum
380 nm ﬂuorescence upon EGTA addition. Fmin is the
minimum 380 nm ﬂuorescence upon 1 mM CaCl2 addition.
Maximal [Ca2+]mito uptake was calculated as Fmax/F0 where
Fmax is the maximum ﬂuorescence intensity and F0 is the mean
resting ﬂuorescence intensity before IP3R stimulation or
SOCE protocol induction.
For [Ca2+]mito vs. [Ca2+]cyto analysis we plotted the mean trace
curve from basal to maximal [Ca2+]cyto in X-axis, with regards to
the same time points corresponding to [Ca2+]mito relative
ﬂuorescence from basal to maximal [Ca2+]cyto, in the Y-axis.
For maximal IP3R-induced [Ca2+]cyto vs maximal [Ca2+]mito
uptake we used the maximal [Ca2+]cyto ± SEM in the X-axis,
and the maximal [Ca2+]mito uptake ±SEM, in the Y-axis. To
quantify the changes in the [Ca2+]mito vs. [Ca2+]cyto we consider
considered the [Ca2+]cyto at the moment of a 2-fold increase in

Cell Transfection
Cells were plated on glass 25 mm coverslips and then transfected
with speciﬁc constructs using Lipofectamine 2,000–3,000
(Invitrogen). MEF cells were transfected pCCEY plasmid
encoding for human OPA1 isoform 1. OPA1 GTPase or GED
mutants were built in the same backbone. For mitochondrial
matrix calcium analysis, we used mitochondrial matrix-targeted
Ca2+-sensitive proteins mtRCaMP (Kd ∼ 1 µM) and CEPIA3mt
(Kd ∼ 10 µM). The transfection was performed with OPTI-mem
(Thermoﬁsher) or Transfectagro (Corning) and lipofectamine 2,000
or 3,000 (Invitrogen, Cat#11668019 or Cat#L300015, respectively)
according to the manufacturer´s protocol. For optimal expression,
the cells were grown for 48 h after transfection. One μg of DNA per
plasmid per 35 mm dish was used for each experiment.
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Philips Tecnai 12 at 80 kV, or at a TALOS F200C G2 system
(Thermo Scientiﬁc), equipped with a Ceta 16M CMOS camera, at
200 kV, at the Advanced Microscopy Facility UMA-UC,
Pontiﬁcia Universidad Católica de Chile. ER-mitochondria
distance analysis was performed with Fiji ImageJ. For ERmitochondria distance measurement we considered the values
≤30 nm.

TABLE 1 | Primers used to build the mutants generated in this work.
Mutant
OPA1 c.870+5G>A
OPA1 c.889C>T
OPA1 c.1334G>A
OPA1 c.2713C>T
OPA1 c.2818+5G>A

Primers
5′
3′
5′
3′
5′
3′
5′
3′
5′
3′

GTTGTTGTGGTTGGAGATC 3′
CTTAAGCTTTCTATGATGAATG 5′
GGTTGGAGATtAGAGTGCTGG 3′
ACAACAACCCGTGGCAGA 5′
GATGCTGAACaCAGTATTGTTAC 3′
CACAGATCCATCTTGAATAC 5′
TGAAGTTAGGtGATTAGAGAAAAATG 3′
GTATTTGTAAGTTGTTGCC 5′
AGAAAGTTAGAGAAATTCAAGAAAAAC 3′
CTTCAGTATTTGTAAGTTGTTG 5′

Western Blot Analysis
Cells were cultured to 70–80% of conﬂuence, harvested, and
frozen. Upon thawing, a membrane-rich lysate was generated by
RIPA buffer supplemented with protease and phosphatase
inhibitors; 30 µg of total protein extracts were loaded into 8%
or 4–12% gradient SDS-PAGE gel and transferred to PVDF
membranes. Membranes were blocked with 5% milk in 0.1%
TBS-Tween for 1 h at RT, followed by overnight incubation with
primary antibody prepared in 5% milk or 3% BSA in 0.1% TBSTween. Secondary antibodies were visualized with enhanced
chemiluminescent substrates (ECL, SuperSignal West Dura or
SuperSignal West Femto, Thermo Scientiﬁc). For MICU1,
MICU2, and EMRE, were used IR LI-COR Bioscience
secondary antibodies. Densitometry was performed using
ImageStudio software (LI-COR Bioscience). Antibodies used in
this study: OPA1(1:1,000, BD Pharmigen #Cat 612607), MICU1
(1:500, Sigma #Cat HPA037479), MICU2 and EMRE (1:1,000,
Bethyl) MCU (1:1,000, Cell signaling #Cat14997, 1:500 SigmaAldrich #Cat HPA016480), mtHSP70 (1:1,000 Invitrogen, #Cat
MA3-028), TIM23 (1:1,000, BD Pharmigen #Cat 611-222),
TOM20 (1:1,000, Proteintech #Cat 11802-1-AP), TUBULIN
(1:1,000 Cell Signaling #Cat 2144S), GAPDH (1:5,000,
Proteintech #Cat 60004-1-lg).

[Ca2+]mito upon CCh stimulation. For SOCE, we considered the
[Ca2+]cyto at the moment of a 1.5-fold increase in [Ca2+]mito for
CCh stimulation.
For ADOA-derived ﬁbroblasts experiments, the cells plated on
glass coverslips were transfected with mtRCaMP and loaded with
Fura2-AM (2 µM). Cells were evaluated in 0.25% BSA-ECM
containing and transferred to the thermostated stage (37°C) of
the microscope. Live-cell image series was performed every 1.5s,
in a Nikon Eclipse Ti inverted microscope with a Lambda
DG4 wavelength-switch xenon light source (Sutter
Instruments) and attached by iXon3 897 Andor EMCCD
camera controlled by NIS software (Nikon). Cells were
stimulated by Histamine to activate the IP3R and induce ER
Ca2+ release. Fura2-AM was evaluated by a dedicated ﬁlter set
cube: ex.340,380—em.535/40 nm, whereas, mtRCaMP was tested
using ex.545—em.620/60 nm Ca2+
cyto transient data were expressed
as 340/380 ratio. To quantify the level of change in the [Ca2+]mito
vs. [Ca2+]cyto we considered the [Ca2+]cyto at the moment of a 1.4fold increase in [Ca2+]mito upon Histamine stimulation.

OPA1 Domain-speciﬁc Mutations Plasmid
Construction

Mitochondrial Membrane Potential
Cells plated on glass coverslips were washed with ECM and loaded
10 min at room temperature with Tetramethyl rhodamine methyl
ester or Tetramethyl rhodamine ethyl ester probe (TMRM 20 nM
for MEF cells or TMRE 10 nM for human ﬁbroblasts) in nonquenching mode. Mitochondrial membrane potential in MEF cells
was measured at the custom-built LED Olympus epiﬂuorescence
imaging system. TMRM was recorded using a 577 nm excitation
ﬁlter, using dual-band dichroic and emission ﬁlters (Chroma,
59022m dual-band ﬁlters). Cells were recorded every 1s.
ADOA-derived cells experiments were performed at the Nikon
Eclipse Ti microscope, using the following conﬁguration: ex. 540
nm—em. 620/60 nm, 1 image every 1.5s. FCCP 5 µM/Oligomycin
5 μg/ml (MEF cells) or FCCP 10 µM (ADOA-derived ﬁbroblasts)
was used to induce loss of mitochondrial membrane potential.
Resting membrane potential was calculated as ΔFbasal—FFCCP
using absolute ﬂuorescence values.

The pCCEY plasmid containing human OPA1 isoform 1 WT
was kindly donated by Guy Lenaers. Mutagenic OPA1 variants
were designed using the Q5 Site-Directed Mutagenesis Kit (New
England Biolabs) and following the manufacturer´s protocol.
The actual generation of speciﬁc mutations was conﬁrmed by
sequencing using the ABI PRISM 3500 xl Applied Biosystems
(FONDEQUIP EQM150077) at Pontiﬁcia Universidad Católica
de Chile or sequenced at Macrogene inc., Seoul, South Korea.
pCCEY plasmid encoding GTPase mutant OPA1 c.899G>A
(G300E) and GED mutant OPA1 c.2708delTTAG was kindly
donated by Guy Lenaers and used in previous studies (Olichon
et al., 2007b; Eisner et al., 2014). For primers’ details, see
Table 1.

Stable Cell Line Generation

Opa1−/− MEFs cells were transfected as described above with a
lentiviral plasmid containing the human OPA1 isoform 1 and a
puromycin resistance cassette (pLenti-OPA1). Transfected cells
were selected with Puromycin 2 μg/ml to obtain a polyclonal
stable cell line. The cells were grown in growth media described
above in presence of Puromycin 2 μg/ml. The pLenti-OPA1 was
obtained from VectorBuilder.

Transmission Electron Microscopy
To evaluate mitochondrial ultrastructure, pellets of 8 × 105 cells
were ﬁxed with glutaraldehyde 2.5%. Staining was performed as
previously described (Csordás et al., 2010). Images of ultra-thin
sections were acquired in a transmission electron microscope
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Image and Statistical Analysis

the Department of Health. NIH grant RO1-HL142271 to GH.
FONDECYT grants 1150677 and 1191770 to VE.

Image acquisition and analysis were performed using Fiji (ImageJ)
software. The statistical analysis was carried out using the
GraphPad Prism 8 Software. For pairwise comparisons,
unpaired t-tests were used for all normally distributed data,
whereas Mann-Whitney tests were used for nonparametric data.
For multiple comparisons, One-way ANOVA followed by
Dunnett’s multiple comparison test was used to determine the
signiﬁcance of normally distributed data. For nonparametric
multiple comparisons, a Kruskal-Wallis test followed by Dunn’s
multiple comparison test was used to determine signiﬁcance (p <
0.05). In all cases, data not indicated as signiﬁcant should be
considered not statistically different.
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Supplementary Figure 1 | (A) Opa1−/−, Opa1−/− +OPA1 WT or WT MEF cells
expressing mtRCaMP, and the muscarinic receptor 3 (M3R), were incubated with
Fura2-AM as described above, and stimulated with 200 µM of Carbachol (CCh) to
induce the release of Ca2+ from the ER to the cytosol via activation of IP3R. The
graph shows resting [Ca2+]cyto. (B) Graph show mean traces of [Ca2+]mito expressed
in arbitrary ﬂuorescence units for mtRCaMP. (C) Resting [Ca2+]mito expressed in
arbitrary ﬂuorescence units. (D) OPA1−/− MEF cells exogenously expressing
CEPIA3mt, M3R, and incubated with TMRM 20nM as described above, were
stimulated with 200 µM of Carbachol to induce the release of Ca2+ from the ER
to the cytosol via activation of IP3R. Graph show mean traces of [Ca2+]mito expressed in
arbitrary ﬂuorescence units (WT, n3/99; preparations/cells; Opa1−/−, n  3/103;
Opa1−/− +OPA1 WT, n  3/99). (E) Resting [Ca2+]mito expressed in arbitrary
ﬂuorescence units. (F) Maximal [Ca2+]mito uptake vs Maximal [Ca2+]cyto amplitude
upon agonist stimulation of WT single cells. (G) Maximal [Ca2+]mito uptake vs Maximal
[Ca2+]cyto amplitude upon agonist stimulation. (H) Opa1−/−, Opa1−/− +OPA1 WT or WT
MEF cells expressing OMMRCaMP were washed and kept in a Ca2+-free medium. The
cells were treated 2µM of Thapsigargin (Tg) (250s) to deplete the ER Ca2+ content. The
graph shows mean traces of [Ca2+]cyto (WT, n2/40; preparations/cells; Opa1−/−, n2/
72; Opa1−/− +OPA1WT, n2/49). (I) [Ca2+]OMM mean traces upon Tg addition. (J) AUC
from [Ca2+]cyto traces (K) AUC from [Ca2+]OMM traces (L) Store Operated Calcium Entry
(SOCE) induction protocol. Prior to stimulation with CCh, cells were washed and kept in
a Ca2+-free medium. To stimulate IP3R, cells were treated with CCh 200 µM (60s),
followed with 2 µM of Tg (200s) to completely deplete the Ca2+ from the ER. Next,
1mM of CaCl2 was added to induce the Store Operated Calcium Entry (SOCE, 500s).
The graph shows mean traces of [Ca2+]cyto. (M) Maximal [Ca2+]cyto amplitude upon
CCh stimulation in Ca2+-free buffer. (N) Maximal [Ca2+]cyto amplitude upon Tg
stimulation in Ca2+-free buffer. (O) Maximal [Ca2+]mito uptake vs Maximal [Ca2+]cyto
amplitude upon SOCE induction. Data are mean ± SEM. Error bars represent SEM.
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs. WT condition. ####p < 0.0001 vs.
Opa1−/− + OPA1 WT condition.
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Supplementary Figure 2 | (A) Western blot analysis of mitochondrial mass markers
for different mitochondrial compartments (Matrix, IMM, OMM). (B) Western blot
densitometry of mitochondrial mass markers for different compartments (Matrix,
IMM, OMM). (C) Western blot analysis of mtCU components in WT, Opa1−/−or acute
rescued Opa1−/− MEF Cells. (D) Western blot densitometry of main mtCU
components. (E) Western blot validation of Opa1−/− +OPA1 WT stable MEFs
cells. Data are mean ± SEM. Error bars represent SEM. *p < 0.05 vs. WT.
Supplementary Figure 3 | (A) Western blot quantiﬁcation of OPA1 levels. (B)
Skin or skeletal muscle ADOA-derived ﬁbroblast expressing mtRCaMP were
loaded with Fura2-AM (2 μM) for 20 min at room temperature. To induce the
release of Ca 2+ through IP3R activation, Histamine 100 μM was used. The bar
chart shows resting [Ca2+ ]cyto . (C) The bar chart shows resting [Ca2+]mito. (D)
Maximal [Ca2+ ]mito uptake vs Maximal IP3R-induced [Ca2+ ]cyto amplitude upon
agonist stimulation. (E) TEM representative images of ER-mitochondria
contacts from ADOA-derived patient cells. ER is pseudo-colored in blue.
Data are mean ± SEM. Error bars represent SEM. **p < 0.01, ***p < 0.001
vs. Control condition.
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Supplementary Figure 4 | (A) Western blot quantiﬁcation of OPA1 levels. (B)
Skin or skeletal muscle ADOA-derived ﬁbroblast expressing mtRCaMP were
loaded with Fura2-AM (2 μM) for 20 min at room temperature. To induce the
release of Ca 2+ through IP3R activation, Histamine 100 μM was used. The bar
chart shows resting [Ca2+ ]cyto . (C) The bar chart shows resting [Ca2+]mito. (D)
Maximal [Ca2+ ]mito uptake vs Maximal IP3R-induced [Ca2+ ]cyto amplitude upon
agonist stimulation. (E) TEM representative images of ER-mitochondria
contacts from ADOA-derived patient cells. ER is pseudo-colored in blue.
Data are mean ± SEM. Error bars represent SEM. **p < 0.01, ***p < 0.001
vs. Control condition. (F) Maximal [Ca 2+]mito uptake vs Maximal [Ca2+]cyto
amplitude induced upon agonist stimulation. (G) Maximal [Ca 2+ ]mito uptake
vs Maximal [Ca 2+]cyto upon SOCE induction. (H) WT MEF cells expressing OPA1

mutants, mtRCaMP, and the muscarinic receptor 3 (M3R), were incubated with
Fura2-AM and stimulated as described above. Graph shows mean traces of
[Ca2+ ]cyto expressed in nM. The bar chart shows resting [Ca 2+ ]cyto . (I) Graphs
show mean traces of [Ca 2+]mito expressed in arbitrary ﬂuorescence
units, evoked by GTPase mutants. (J) Graphs show mean traces of
[Ca2+ ]mito expressed in arbitrary ﬂuorescence units, evoked by GED
mutants. (K) The bar chart shows resting [Ca 2+]mito. (L) Maximal [Ca 2+] mito
vs Maximal [Ca2+]cyto amplitude induced upon agonist stimulation. Data
are mean SEM. Error bars represent SEM. pp < 0.05, ppp < 0.01 vs Opa1−/
− or WT condition. #p < 0.05, ##p < 0.01 vs Opa1 −/− + OPA1 WT condition.
The blue color is indicative of GTPase mutants and the red color for GED
mutants.
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